NCT04405258View on ClinicalTrials.gov

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

June 8, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Persistent Atrial FibrillationCatheter AblationPulmonary Vein IsolationPosterior Wall Isolation
Interventions
PROCEDURE

Pulmonary vein isolation

Pulmonary vein isolation, superior vena cava isolation, and cavotricuspid isthmus ablation

PROCEDURE

Left posterior wall isolation

Pulmonary vein isolation, superior vena cava isolation, cavotricuspid isthmus ablation, and left posterior wall isolation

Trial Locations (1)

760-8557

Kagawa Prefectural Central Hospital, Takamatsu

All Listed Sponsors
lead

Institute for Clinical Effectiveness, Japan

OTHER